Cryoport
CYRX on Nasdaq. Cryoport sells temperature-controlled storage and shipping for cell and gene therapies to life sciences companies. Market value $919m.
Price checks use the past 12 months to June 2026. Some use the latest annual report instead, as marked. Quality checks use five annual reports, the latest for the year to December 2025.
We can't read total debt from the filing, so debt is left out.
Should I look at this?
Not a fit for our list right now
Why it could be worth it
Nothing stands out yet.
See Health care stocks that passed both tests
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $-2.24 of spare cash in the past 12 months. A savings account pays about $4.
The filings do not give us enough to work this out.
The filings do not give us enough to work this out.
Quality score: 40 of 100. Price score: 33 of 100. Our list needs 70 on quality and 60 on price.
$17.80 a share, 134% above its 1-year low
Over the past year the price has ranged from $7.61 to $18.36.
Pays no dividend
Prices from Tuesday’s close (6 October).
Five years of cash, in billions
| Revenue | |||||
| Revenue | $223m | $237m | $169m | $157m | $176m |
| Operating margin | |||||
| Operating margin | -8.0% | -13.4% | -59.6% | -77.6% | -20.9% |
| Debt to equity | |||||
| Debt to equity | n/a | n/a | n/a | n/a | n/a |
| Shares outstanding | |||||
| Shares outstanding | 0.05bn | 0.05bn | 0.05bn | 0.05bn | 0.05bn |
Health checks
- Free cash flow positive0 of 5 years
- Accounting looks honest (Beneish)Not enough data
- Financial strength (Piotroski)5 of 8 checks we could run
- Profit backed by cash (accruals)No
- DebtUnknown
- Revenue growth, five yearsStrong, 17.5% a year
- Buying back its own sharesRoughly flat
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $49 million last quarter, up 8% on a year ago.
- A loss of $8 million, after a profit of $109 million a year ago.
- It loses 21 cents on each $1 of sales, compared with 26 cents a year earlier.
- Over the past 12 months it spent $20 million more cash than it brought in, compared with $37 million a year earlier.
- About the same number of shares as a year ago.
| Quarter to | Amount |
|---|---|
| September 2024 | $38m |
| December 2024 | Not reported |
| March 2025 | $41m |
| June 2025 | $45m |
| September 2025 | $44m |
| December 2025 | $45m |
| March 2026 | $48m |
| June 2026 | $49m |
| Quarter to | Amount |
|---|---|
| September 2024 | $805,000 |
| December 2024 | -$19m |
| March 2025 | -$12m |
| June 2025 | $109m |
| September 2025 | -$7m |
| December 2025 | -$12m |
| March 2026 | -$11m |
| June 2026 | -$8m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 5 March 2026
- Next quarterly (estimated, 10-Q)
- 5 November 2026
Who owns it
1 long-term investor we follow owns it, unchanged from 1 last quarter. 185 funds in all.
| Fund | Value | Share of that fund | Change |
|---|---|---|---|
| First Eagle Investment ManagementMatthew McLennan | $40m | <0.1% | Added |
Largest holders overall
- BlackRock$66mAdded
- Cadian Capital Management, LP$46mCut
- First Eagle Investment Management$40mAdded
- Assenagon Asset Management$36mAdded
- Morgan Stanley$36mCut
- Vanguard Capital Management$34m
- Millennium Management$27mCut
- Fred Alger Management$24mCut
- Geode Capital Management$21mAdded
- MAK Capital One$20mCut
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
3 investors own more than 5%.
- Cadian Capital Management, LPPassive investorat least 5.8%−4.2 pts(filed with 2 related holders)Since 30 June 2026
- Morgan StanleyPassive investorat least 4.5%(filed with 1 related holder)Since 30 June 2026
- Millennium Management LLCPassive investorat least 3.4%−3.1 pts(filed with 3 related holders)Since 30 June 2026
- Alger Associates, Inc.Passive investorSold down below 5%Since 30 June 2025
- Brown Capital Management, LLCPassive investorSold down below 5%Since 31 December 2025
- The Vanguard GroupPassive investorSold down below 5%Since 13 March 2026
| Holder | Stake | Since | |
|---|---|---|---|
Cadian Capital Management, LP Passive investor | at least 5.8%−4.2 pts (filed with 2 related holders) | 30 June 2026 | |
Morgan Stanley Passive investor | at least 4.5% (filed with 1 related holder) | 30 June 2026 | |
Millennium Management LLC Passive investor | at least 3.4%−3.1 pts (filed with 3 related holders) | 30 June 2026 | |
Alger Associates, Inc. Passive investor | Sold down below 5% | 30 June 2025 | |
Brown Capital Management, LLC Passive investor | Sold down below 5% | 31 December 2025 | |
The Vanguard Group Passive investor | Sold down below 5% | 13 March 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought shares on the open market in the last 12 months. 5 sold $5m, $429,385 of it under preset trading plans.
- SHELTON JERRELLPresident, CEO, DirectorSoldunder a preset trading plan
- Date
- 11 August 2026
- Shares
- 28,800
- Price
- $14.91
- Value
- $429,385
- ZECCHINI EDWARD JChief Digital and Tech OfficerSold
- Date
- 11 June 2026
- Shares
- 33,600
- Price
- $14.47
- Value
- $486,192
- ZECCHINI EDWARD JChief Digital and Tech OfficerSold
- Date
- 10 June 2026
- Shares
- 1,400
- Price
- $15.23
- Value
- $21,322
- Mandalam RamkumarDirectorSold
- Date
- 8 June 2026
- Shares
- 23,214
- Price
- $15.44
- Value
- $358,424
- STEFANOVICH ROBERTChief Financial OfficerSold
- Date
- 4 June 2026
- Shares
- 169,427
- Price
- $16.27
- Value
- $3m
- STEFANOVICH ROBERTChief Financial OfficerSold
- Date
- 23 March 2026
- Shares
- 1,094
- Price
- $8.18
- Value
- $8,949
- SHELTON JERRELLPresident, CEO, DirectorSold
- Date
- 23 March 2026
- Shares
- 2,894
- Price
- $8.18
- Value
- $23,673
- Sawicki Mark WChief Scientific OfficerSold
- Date
- 23 March 2026
- Shares
- 1,341
- Price
- $8.18
- Value
- $10,969
- ZECCHINI EDWARD JSee RemarksSold
- Date
- 16 March 2026
- Shares
- 2,014
- Price
- $8.00
- Value
- $16,112
- SHELTON JERRELLPresident, CEO, DirectorSold
- Date
- 16 March 2026
- Shares
- 7,918
- Price
- $8.00
- Value
- $63,344
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 11 August 2026 | SHELTON JERRELL President, CEO, Director | Sold under a preset trading plan | 28,800 | $14.91 | $429,385 |
| 11 June 2026 | ZECCHINI EDWARD J Chief Digital and Tech Officer | Sold | 33,600 | $14.47 | $486,192 |
| 10 June 2026 | ZECCHINI EDWARD J Chief Digital and Tech Officer | Sold | 1,400 | $15.23 | $21,322 |
| 8 June 2026 | Mandalam Ramkumar Director | Sold | 23,214 | $15.44 | $358,424 |
| 4 June 2026 | STEFANOVICH ROBERT Chief Financial Officer | Sold | 169,427 | $16.27 | $3m |
| 23 March 2026 | STEFANOVICH ROBERT Chief Financial Officer | Sold | 1,094 | $8.18 | $8,949 |
| 23 March 2026 | SHELTON JERRELL President, CEO, Director | Sold | 2,894 | $8.18 | $23,673 |
| 23 March 2026 | Sawicki Mark W Chief Scientific Officer | Sold | 1,341 | $8.18 | $10,969 |
| 16 March 2026 | ZECCHINI EDWARD J See Remarks | Sold | 2,014 | $8.00 | $16,112 |
| 16 March 2026 | SHELTON JERRELL President, CEO, Director | Sold | 7,918 | $8.00 | $63,344 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
None of the warning signs we check for were found.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 5 Mar 2026, plus the 10-Q filed 6 Aug 2026 and 3 later 8-Ks.
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
- Profits run ahead of cash.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.